Atlas Trials

Clinical Significance of Germline BRCA Mutations

Clinical trial NCT00579488 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT00579488
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Breast CancerOvarian Cancer
Start date
1996-07-01
Primary completion
2027-07-01
Enrollment
13320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.